The optimum time for tumour imaging with thallium-201

Area of Science:

• Nuclear Medicine
• Oncology
• Radiopharmacology

Background:

• Thallium-201 (201Tl) is a radiotracer used in nuclear medicine.
• Understanding 201Tl uptake kinetics in tumors is crucial for diagnostic imaging.
• Previous studies have investigated 201Tl myocardial uptake, but tumor kinetics require further elucidation.

Purpose of the Study:

• To assess the uptake kinetics of 201Tl-chloride in primary tumors of lung cancer, breast cancer, and mediastinal lymphoma patients.
• To compare tumor uptake kinetics with myocardial uptake.
• To determine the optimal imaging time for 201Tl tumor visualization.

Main Methods:

• Intravenous injection of 75 MBq 201Tl-chloride in 56 lung cancer, 26 breast cancer, and 13 lymphoma patients.
• Assessment of 201Tl uptake kinetics in myocardium and primary tumors.
• Measurement of time to maximal tumor uptake, maximal cardiac uptake, and tumor-to-background activity.
• Evaluation of 201Tl washout from tumors in the first hour post-injection.

Main Results:

• Maximal tumor uptake occurred between 8-20 minutes post-injection, with no significant difference between cancer types.
• Maximal cardiac uptake of 201Tl was observed around 11.61 minutes.
• No significant 201Tl washout from tumors was observed within the first hour.
• Optimal tumor imaging time, based on tumor-to-background activity, varied by cancer type but generally occurred later than peak uptake.

Conclusions:

• The time course of 201Tl uptake in tumors suggests a mechanism similar to myocardial uptake.
• The optimal time for 201Tl tumor imaging is between 20-60 minutes post-injection, irrespective of tumor type.
• These findings support the use of 201Tl for tumor imaging in various malignancies, guiding optimal imaging protocols.